Invention Grant
- Patent Title: Treatment of hepatitis delta virus infection
-
Application No.: US16996147Application Date: 2020-08-18
-
Publication No.: US11311519B2Publication Date: 2022-04-26
- Inventor: David A. Cory , Ingrid Choong , Jeffrey S. Glenn
- Applicant: Eiger Biopharmaceuticals, Inc.
- Applicant Address: US CA Palo Alto
- Assignee: Eiger Biopharmaceuticals, Inc.
- Current Assignee: Eiger Biopharmaceuticals, Inc.
- Current Assignee Address: US CA Palo Alto
- Agency: Kilpatrick Townsend & Stockton
- Main IPC: A61K31/427
- IPC: A61K31/427 ; A61K31/4545 ; A61K9/00 ; A61K38/21 ; A61K9/14 ; A61K47/60
Abstract:
Methods of reducing hepatitis delta virus (HDV) viral loads in a patient are provided. In some embodiments, the method comprises treating the patient with lonafarnib-ritonavir co-therapy. In some embodiments, the method further comprises treating the patient with an interferon.
Public/Granted literature
- US20200375955A1 TREATMENT OF HEPATITIS DELTA VIRUS INFECTION Public/Granted day:2020-12-03
Information query
IPC分类:
